We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
New operative technique for treatment of xanthelasma palpebrarum: laser-inverted resurfacing: preliminary report.
Annals of Plastic Surgery 2003 April
Xanthelasma palpebrarum lesions are benign but present cosmetic problems to the patient. Their surgical removal has also presented problems to the surgeon. A new laser operative technique for xanthelasma palpebrarum is introduced to avoid the risk for scarring and pigmentary changes after vaporization of eyelid tissue to remove benign lesions, for example, xanthelasma. The authors propose pulsed erbium yttrium aluminum garnet (Er:YAG) vaporization of the lipomatous tissue off the inner surface of the eyelid after incision and eversion of the incised tissue to expose the xanthelasma. The Er:YAG is the laser of choice because of its high absorption in water and thus its self-limiting depth of penetration coupled with extremely precise tissue ablation. Two illustrative case reports are presented, with no recurrence seen in a maximum of 1 year of follow-up. This technique offers the following advantages: no excision of tumor tissue is required (bearing in mind the high rate of recurrence of this lesion) and this wavelength allows good control of tissue removal and accurate recognition of the end point.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app